TCM
Tamarack Capital Management Portfolio holdings
AUM
$503M
This Quarter Return
-1.34%
1 Year Return
+15.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$328M
AUM Growth
+$328M
(-9.2%)
Cap. Flow
-$22.7M
Cap. Flow
% of AUM
-6.9%
Top 10 Holdings %
Top 10 Hldgs %
65.2%
Holding
38
New
7
Increased
13
Reduced
5
Closed
7
Top Buys
| 1 |
Medtronic
MDT
|
$22.9M |
| 2 |
ELGX
Endologix Inc
ELGX
|
$9.81M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$7.6M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$7.3M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
$6.01M |
Top Sells
Sector Composition
| 1 | Healthcare | 77.33% |
| 2 | Technology | 1.42% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
1
DELISTED
Endologix Inc
ELGX
| $35M | 7.75% | 3,300,000 +925,000 | +39% | +$9.81M |
|
|
SPNC
2
DELISTED
Spectranetics Corp
SPNC
| $30.6M | 6.77% | 1,150,000 | – | – |
|
|
3
Medtronic
MDT
$119B
| $22.9M | 5.08% | +370,000 | New | +$22.9M |
|
|
CFN
4
DELISTED
CAREFUSION CORPORATION
CFN
| $22.6M | 5.02% | 500,000 -375,000 | -43% | -$17M |
|
5
Integer Holdings
ITGR
$3.78B
| $20.2M | 4.48% | 474,730 +104,830 | +28% | +$4.47M |
|
|
AUXL
6
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $19.4M | 4.3% | 650,000 -293,526 | -31% | -$8.76M |
|
7
Alkermes
ALKS
$4.78B
| $19.3M | 4.28% | 450,000 -75,000 | -14% | -$3.22M |
|
|
PDCO
8
DELISTED
Patterson Companies, Inc.
PDCO
| $15.3M | 3.4% | 370,000 +145,000 | +64% | +$6.01M |
|
|
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
| $14.4M | 3.2% | 1,100,000 +50,000 | +5% | +$657K |
|
10
MiMedx Group
MDXG
$1.05B
| $14.3M | 3.16% | 2,000,000 +225,000 | +13% | +$1.6M |
|
11
Teva Pharmaceuticals
TEVA
$21.1B
| $12.4M | 2.74% | 230,000 -16,500 | -7% | -$887K |
|
|
LMNX
12
DELISTED
Luminex Corp
LMNX
| $10.7M | 2.38% | 550,000 +50,000 | +10% | +$975K |
|
|
SRGA
13
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $10.5M | 2.33% | 2,200,000 +50,000 | +2% | +$239K |
|
14
AtriCure
ATRC
$1.84B
| $10.3M | 2.28% | 700,000 +113,445 | +19% | +$1.67M |
|
|
15
Bio-Rad Laboratories Class A
BIO
$8.06B
| $9.46M | 2.1% | 83,378 +67,009 | +409% | +$7.6M |
|
|
NTUS
16
DELISTED
Natus Medical Inc
NTUS
| $8.11M | 1.8% | 274,695 +121,162 | +79% | +$3.58M |
|
|
CBST
17
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $7.3M | 1.62% | +110,000 | New | +$7.3M |
|
18
Inogen
INGN
$216M
| $5.37M | 1.19% | +260,617 | New | +$5.37M |
|
|
VOLC
19
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $5.32M | 1.18% | 500,000 -1,518,300 | -75% | -$16.2M |
|
|
STRM
20
DELISTED
Streamline Health Solutions
STRM
| $5.27M | 1.17% | 1,138,000 +113,000 | +11% | +$523K |
|
21
ICU Medical
ICUI
$3.15B
| $5.14M | 1.14% | +80,125 | New | +$5.14M |
|
|
IMPR
22
DELISTED
IMPRIVATA, INC COM
IMPR
| $4.66M | 1.03% | 300,000 +104,447 | +53% | +$1.62M |
|
23
Becton Dickinson
BDX
$55.3B
| $4.55M | 1.01% | +40,000 | New | +$4.55M |
|
24
DexCom
DXCM
$29.5B
| $4.2M | 0.93% | +105,000 | New | +$4.2M |
|
|
HNGR
25
DELISTED
Hanger Inc.
HNGR
| $4.1M | 0.91% | +200,000 | New | +$4.1M |
|